It had long been understood that the anti-Covid vaccine was a golden business for producers. It was enough to go and reread the forecasts on future revenues formulated by Pfizer and Moderna in recent months. The US giant led by Albert Bourla (pictured above with US President Joe Biden) he estimated additional revenues in the solo 2021 for 15 billion dollars from his vaccine. A figure that alone is worth almost 40% of the entire annual worldwide turnover by Pfizer. And from those 15 billion dollars from the sales of his serum, the American house estimates operating profits between 3 and 4 billion.
Analogous speech for Modern. The ex microphone biotech American thanks to its vaccine (the most expensive on the market at a price close to i 19 euro a dose) it will pass from just 800 million in turnover to 18 billion this year. An epochal change of pace, a phenomenal acceleration with net profits to explode well over 4 billion dollars.
The gold rush
The stellar earnings that the various Pfizer and Moderna will achieve, they are certainly children of the revenue boom, but also of very low costs for research and production. The proof is not only in the balance sheets of the two houses, but in the contract documents che were signed with the European Commission is that Report has published in full. Well those contracts are revealed, at least for Moderna, even the production costs. Let’s see them.
The costs of producing vaccines
The company led by Stephane Bancel will spend to produce 80 million doses for Europe and which will yield revenues of over 1.6 billion euros, A little bit more than 300 million euros. 20% of the sales value. 84 million will cost raw materials to produce the whey; 173 million for production; and other 40 million between logistics costs and regulatory charges.
If you replicate the European Commission’s scheme across the globe, that’s it Moderna will sell its vaccine for nearly 6 times its direct costs. Of course, then there are the research and development costs. From the Moderna budgets, in 2020 the expenses for research and development of the Covid vaccine amounted to just over 800 million dollars. It is the total expense that led to the discovery of the vaccine they were signed for purchase agreements for 2021 for ben $ 18.4 billion.
From the Pfizer contract the details of the costs are missing. But something can be recovered from the budgets of the US giant. For vaccine research and development, discovered in tandem with Biontech, has been spent $ 1 billion last year. The costs of the discovery will bring in 2021, only on the basis of the purchase agreements already signed in the world, a sales receipts of $ 15 billion.
(Continued: Pfizer and Biontech’s costs of producing the vaccine)